This proprietary platform creates a predictive and programmable framework for precise cellular engineering by integrating single-cell analytics with chemical reprogramming. Its power lies in its extensibility and precision — it is designed to decode and direct fundamental biological pathways, enabling targeted fate redirection across diverse cell types without genetic modification.
Applied to T-cell therapy, this system directly tackles the central barriers in treating solid tumors. It produces rejuvenated T cells with three transformative attributes:
Together, these capabilities are not merely incremental improvements—they represent a foundational shift in how potent, persistent, and accessible cell therapies can be engineered.